Menu
GWAS Study

A Genome Wide Association Study on plasma FV levels identified PLXDC2 as a new modifier of the coagulation process.

Thibord F, Hardy L, Ibrahim-Kosta M et al.

31271701 PubMed ID
GWAS Study Type
1666 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TF
Thibord F
HL
Hardy L
IM
Ibrahim-Kosta M
SN
Saut N
PA
Pulcrano-Nicolas AS
GL
Goumidi L
CM
Civelek M
EP
Eriksson P
DJ
Deleuze JF
LG
Le Goff W
TD
Trégouët DA
MP
Morange PE
Chapter II

Abstract

Summary of the research findings

Factor V (FV) is a circulating protein primarily synthesized in the liver, and mainly present in plasma. It is a major component of the coagulation process.

510 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

1666
Total Participants
GWAS
Study Type
Yes
Replicated
1,156 European ancestry individuals
Replication Participants
European
Ancestry
France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.